Objectives: Identification (ID) of pathogens by conventional methods from liquid culture media requires 24–48 hour. Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) is a new molecular diagnostic tool for the rapid ID of pathogens directly from liquid media. The aims of this study were to evaluate PNA FISH in comparison with conventional methods both from positive blood cultures (BC) and other biological fluids, as well as to evaluate the ID of Streptococcus agalactiae (GBS) from vaginal swabs (VS) in pregnant women. Methods: The PNA FISH assays (AdvanDx) were applied on 61 positive BC bottles (Bactec 9240, BD) (56 blood samples and five biological fluids other than blood). On the basis of the Gram stain microscopy results, four different panels were used: one for identification/differentiation of Staphylococcus aureus (SA) and other coagulase-negative staphylococci (CNS), one for Enterococcus faecalis (EF) and other enterococci (OE), one for Escherichia coli (EC), Klebsiella pneumoniae (KP) and Pseudomonas aeruginosa (PA), and one for Candida albicans/C. parapsilosis (CAP), C. tropicalis (CT) and C. glabrata/C. krusei (CGK). For GBS ID, ‘‘GBS PNA FISH’’ assay (AdvanDx) was performed on 25 VS belonging to pregnant women after 24 hour of incubation in enrichment broth. The results of the molecular assays were compared with those obtained by ID with conventional methods. Results: On all 56 positive BC, PNA FISH assays showed a 100% agreement with the ID obtained by conventional methods (14 CNS, four SA, five EF, one SA + EF, one OE, nine EC, two KP, two PA, three CAP, one CGK, one CT, 14 negative). When PNA FISH assays were tested on the two peritoneal fluids, one cerebrospinal fluid, one bile and one liver abscess, the results agreed with the conventional methods in all cases (one EF + EC, one CGK, one CNS, one OE, one OE + CAP). PNA FISH assays provided species identification in average 2.8 days before the conventional methods. ‘‘GBS PNA FISH’’ tested on 25 VS, all samples showed a 100% agreement with conventional methods providing species identification in average 1 day before than conventional method. Conclusion: PNA FISH assays showed, even if tested in this study only on a limited number of samples, an excellent efficacy in the rapid identification of main pathogens yielding a significant reduction on reporting time, leading to a more appropriate patient management and therapy in case of sepsis and severe infections and a rapid screening for GBS colonization in pregnant women.

Evaluation of PNA FISH assays for the rapid diagnosis of sepsis and other severe infections, and identification of Streptococcus agalactiae in the screening of pregnant women / Calderaro, Adriana; Martinelli, Monica; Motta, Federica; Benecchi, Magda; Covan, Silvia; Chezzi, Carlo. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 18, S3:(2012), pp. 504-504. (Intervento presentato al convegno 22nd European Congress of Clinical Microbiology and Infectious Diseases tenutosi a London nel 31 Marzo - 4 Aprile 2012) [10.1111/j.1469-0691.2012.03802.x].

Evaluation of PNA FISH assays for the rapid diagnosis of sepsis and other severe infections, and identification of Streptococcus agalactiae in the screening of pregnant women

CALDERARO, Adriana;MARTINELLI, Monica;MOTTA, Federica;BENECCHI, MAGDA;COVAN, Silvia;CHEZZI, Carlo
2012-01-01

Abstract

Objectives: Identification (ID) of pathogens by conventional methods from liquid culture media requires 24–48 hour. Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) is a new molecular diagnostic tool for the rapid ID of pathogens directly from liquid media. The aims of this study were to evaluate PNA FISH in comparison with conventional methods both from positive blood cultures (BC) and other biological fluids, as well as to evaluate the ID of Streptococcus agalactiae (GBS) from vaginal swabs (VS) in pregnant women. Methods: The PNA FISH assays (AdvanDx) were applied on 61 positive BC bottles (Bactec 9240, BD) (56 blood samples and five biological fluids other than blood). On the basis of the Gram stain microscopy results, four different panels were used: one for identification/differentiation of Staphylococcus aureus (SA) and other coagulase-negative staphylococci (CNS), one for Enterococcus faecalis (EF) and other enterococci (OE), one for Escherichia coli (EC), Klebsiella pneumoniae (KP) and Pseudomonas aeruginosa (PA), and one for Candida albicans/C. parapsilosis (CAP), C. tropicalis (CT) and C. glabrata/C. krusei (CGK). For GBS ID, ‘‘GBS PNA FISH’’ assay (AdvanDx) was performed on 25 VS belonging to pregnant women after 24 hour of incubation in enrichment broth. The results of the molecular assays were compared with those obtained by ID with conventional methods. Results: On all 56 positive BC, PNA FISH assays showed a 100% agreement with the ID obtained by conventional methods (14 CNS, four SA, five EF, one SA + EF, one OE, nine EC, two KP, two PA, three CAP, one CGK, one CT, 14 negative). When PNA FISH assays were tested on the two peritoneal fluids, one cerebrospinal fluid, one bile and one liver abscess, the results agreed with the conventional methods in all cases (one EF + EC, one CGK, one CNS, one OE, one OE + CAP). PNA FISH assays provided species identification in average 2.8 days before the conventional methods. ‘‘GBS PNA FISH’’ tested on 25 VS, all samples showed a 100% agreement with conventional methods providing species identification in average 1 day before than conventional method. Conclusion: PNA FISH assays showed, even if tested in this study only on a limited number of samples, an excellent efficacy in the rapid identification of main pathogens yielding a significant reduction on reporting time, leading to a more appropriate patient management and therapy in case of sepsis and severe infections and a rapid screening for GBS colonization in pregnant women.
2012
Evaluation of PNA FISH assays for the rapid diagnosis of sepsis and other severe infections, and identification of Streptococcus agalactiae in the screening of pregnant women / Calderaro, Adriana; Martinelli, Monica; Motta, Federica; Benecchi, Magda; Covan, Silvia; Chezzi, Carlo. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 18, S3:(2012), pp. 504-504. (Intervento presentato al convegno 22nd European Congress of Clinical Microbiology and Infectious Diseases tenutosi a London nel 31 Marzo - 4 Aprile 2012) [10.1111/j.1469-0691.2012.03802.x].
File in questo prodotto:
File Dimensione Formato  
Calderaro A et al., 2012b abstract IF.pdf

non disponibili

Tipologia: Abstract
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 64.89 kB
Formato Adobe PDF
64.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2433196
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact